CURRENCY FOR HEALTH
Canabio (CNB) is tradable on:
Canabio is a registered trademark, manufactured with GMP cetificate on basis of the highest quality with certificate, natural produced, organic cannabinoid oil. This is the main substance of magistral medicine CanabioTM produced with carefully selected recipe which patented. The fact is that different types of cannabis contain higher or lower levels of cannabinoids, whose task is to activate membrane receptors. CanabioTM with its carefully chosen recipe and continuous testing of quality and balance of components, provides users constant and superior level of therapy without the risks. The registered trademark is used exclusively for medical purposes only.
To provide leading products and services in the legal Cannabis Industry in Central European Countries baseed on the best standards, best quality, transparency, integrity & accountability, CanabioTM established cooperation with distinguished institutions as Faculty of Pharmacy University of Ljubljana, Slovenia (Quality Managment, Quality Control, Quality Assurance), Slovenian Institute of Hop Research and Brewing (Cannabis breeding - development of the most appropriate hybrid), The Institute of Immunology Zagreb, Croatia, National Institute for Biology, Slovenia (research of influence of canabis on tumors - glioma as diagnostic and therapeutic targets)...
Canabio TherapyTM with our expert team successfully providing treatments to the patients in Sveti Martin na Muri (Croatia). Once blood test results from certified lab received, our expert team prepare personalized cocktail Therapy. Therapy includes beside CanabioTM also several Vitamin Therapy, DCA Therapy, Ozon Therapy, Oxygene Therapy, Myer’s Cocktail Therapy, PEMF Therapy - include several types of cancer, (brain, lungs, liver, prostate, stomach, breast, uterine, etc.) rheumatoid arthritis and osteoarthritis, multiple sclerosis, diabetes, glaucoma, epilepsy, psoriasis, anorexia, asthma, inflammatory bowel disease, etc.
Ana Vidič has a Bachelor of Science in Molecular and Cell Biology Louisiana Tech University, Ruston, Louisiana, Bachelor of Science in Management Louisiana Tech University, Ruston Louisiana and Associate Degree in Transfer (Business Administration) Lee College, Baytown, Texas. She worked at Lek Pharmaceuticals d.d. Menges, Slovenia QC Bioanalytic. Research experience Ruston, Los Angeles. Undergraduate Research Assistant in the laboratory of Dr. Jaime Newman working with Mammalian cell culture and molecular biology. Bridges International Ruston, Los Angeles, Administrative Team Member at a non-profit organization for international students.
Damir Štajcar is a specialist in urological department OB Vraždin, a medical director and director of the Sveti Nikola Pole Clinic and also a director and shareholder of the company IQCURE d.o.o. where he works on the development of a health tourism project in IQURE and on the development of a software for the telemedicine center. He is the leader of the training center of IQCURE within the Toplica SV. Martin, director of the Polyclinic Med Vital within the Toplica Sv. Martin and medical director of IQCURE Resort Toplice Sv. Martin.
Jakob Kuess is a Managing Director at Alpha Project and Mining GmbH Austria and Managing Director at Alpha Project Pvt. Ltd. Zimbabwe and has a Mining License and Mining project Kadoma/Zimbabwe. He is a graduate engineer at Technical University Graz in Industrial engineering and management. He has 30 years experience in International Projects and in Construction Development in Austria, Slovenia, Croatia, Bosnia, Ukraine.
Anton Majzelj is a chemistry master, a programmer analyst and the Deputy Director of General Security, physical and technical protection. He is the founder of mobile telephony in Slovenia, the CEO of the company Mobitel and at the same time a member of the management board of Telekom. As a member of the Supervisory Board, he worked in Pivovarna Union, Gorenje, RTV Slovenia, ELES, Zavarovalnica Triglav and IECD Business School Bled.
Prof. Tamara Lah is the Director of National Institute of Biology in Ljubljana, leading the 3rd largest public research institution for natural sciences. Before becoming Director she was Visiting Professor and Director of Metastasis Research Laboratory at Albert Einstein Medical Centre, Philadelphia, Pennsylvania, USA. She was also Head of Department of Genetic Toxicology and Cancer Biology and is still the programme leader of this research group. Since 1999 she is also Full Professor at Biotechnical Faculty and Faculty of Chemistry Chemical Engineering of the University of Ljubljana.
Venessa Kocman is currently self-employed. She worked at Pan d.o.o. as an assistant project manager where she was in charge of contacting the media, preparing media plans and preparing reports for the client. She also worked in Rebus d.o.o. as a supervisor of the OLN system where she carried out monthly business reports, produced monthly and annual reports for internal use and reports for the MF-DURS. In the early years, she worked as a cashier, making betting forms for Rebus d.o.o.
| Field | Plant | CNB | 30 days return | Return CNB | 360 days return |
|---|---|---|---|---|---|
| early birds | 2000 | 1,600,000 | 6% | 1,152,000 | 72% |
| 1 | 3000 | 2,400,000 | 4% | 1,152,000 | 48% |
| 2 | 5000 | 4,000,000 | 3% | 1,440,000 | 36% |
| 3 | 5000 | 4,000,000 | 2.5% | 1,200,000 | 30% |
| 4 | 5000 | 4,000,000 | 2% | 960,000 | 24% |
| 5 | 5000 | 4,000,000 | 1.5% | 720,000 | 18% |
| 6 | 5000 | 4,000,000 | 1% | 480,000 | 12% |
In order to ensure sufficient CNB for the Revard pool, we dedicate 10% of the net profit in all our production centers
For Terms click here
CANABIO - CURRENCY FOR HEALTH
a BlockChain based
European Cannabis Health
Advanced Investment Project